GRT Capital leads Series B round for Aussie biopharma firm EnGeneIC

Australian biopharmaceutical firm EnGeneIC has secured $10 million in Series B funding. GRT Capital Partners led the round with participation from other investors that included Foley Ventures. Also, the company has named Anjan Chatterji as executive vice president of corporate development for its newly launched New York City office.

Montage Secures Investment Led by BVP, GCI and Calumet

Montage Talent, a provider of video interviewing solutions, has received a $4 million investment. The round was led by existing investors Baird Venture Partners, GCI and Calumet Venture Fund, and included participation from new investors The State of Wisconsin Investment Board and Foley Ventures.

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget